Zydus Cadila obtains FDA nod for generic ImbruvicaZydus is the first company to receive approval for generic ibrutinib 70-mg capsules. Camber intros generic Urocit-KCamber's generic Urocit-K tablets provide a treatment for patients with a kidney stone condition called renal tubular acidosis. Dr. Reddy's intros generic Kuvan Dr. Reddy's generic Kuvan offers a treatment for a rare disease. Mayne Pharma launches generic Ortho-Cept Mayne has now launched four generic oral contraceptives with a combined market value of roughly $315 million for the 12 months ending January 2021. Aurobindo launches generic Astelin Camber intros generic Quelicin Camber's generic Quelicin is used as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. FDA greenlights Aurobindo’s generic potassium chloride Aurobindo's generic potassium chloride ER tablets will be offered in dosage strengths of 10 mEq, 15 mEq, and 20 mEq. Amneal acquires Kashiv Specialty Pharmaceuticals Through the acquisition of Kashiv Specialty Pharmaceuticals, Amneal has gained a pipeline of 505(b)2 branded products and complex generics. FDA gives tentative nod to Zydus Cadila's generic Truvada Zydus Cadila's generic Truvada obtained the FDA's tentative approval in three dosage strengths. Amphastar receives FDA green light for dextrose injection Amphastar has received the FDA's blessing for dextrose injection 50% in the 50-ml Luer-Jet Prefilled Syringe system. First Previous 130 131 132 133 134 Next Last
